New England Research & Management, Inc.

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1596077 CHICAGO, IL

Position in VRTX

as of Jun 30, 2026 · filed Jul 9, 2026 Compact

Position Value

$1,279,079

+$564,615 QoQ

Shares Held

2,575

+60.9% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.50%

of 13F equity value

Holder Rank

#788

of 1,735 holders

Holding Since

Dec 2022

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

New England Research & Management, Inc. holds $4,649,048 across 5 Biotechnology names. VRTX ranks #2 (27.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	3,475	$2,166,801
2	VRTX	Vertex Pharmaceuticals Inc / Ma This page	2,575	$1,279,079
3	MRNA	Moderna, Inc.	6,850	$479,705
4	INCY	Incyte Corp	3,575	$405,262
5	AXSM	Axsome Therapeutics, Inc.	1,300	$318,201

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,279,079	2,575	+60.9%	Shares	Sole	2026-07-09
2026-03-31	$714,464	1,600	+4.2%	Shares	Sole	2026-05-07
2025-09-30	$601,167	1,535	+44.8%	Shares	Sole	2025-10-06
2025-06-30	$471,912	1,060	-76.8%	Shares	Sole	2025-07-09
2024-09-30	$2,127,741	4,575	+67.3%	Shares	Sole	2024-10-07
2024-06-30	$1,281,949	2,735	-3.5%	Shares	Sole	2024-07-09
2024-03-31	$1,185,058	2,835	+14.5%	Shares	Sole	2024-04-16
2023-03-31	$779,798	2,475	+160.5%	Shares	Sole	2023-04-06
2022-12-31	$274,341	950	—	Shares	Sole	2023-01-09
No filing history on record for this holder in this stock.